跳到主要內容
:::

黃英彥

高雄長庚醫院放射腫瘤科教授級主治醫師

放射腫瘤科

腫瘤學 輻射生物學 生物統計學 放射治療副作用臨床及基礎醫學研究 放射治療效果之轉譯研究 癌症醣蛋白研究 癌症登記資料庫分析 婦癌放射治療 乳癌放射治療 直腸癌放射治療 肺癌放射治療 血液及淋巴腫瘤放射治療 電腦刀立體定位放射治療 質子治療

教職 : 教授

醫師網路掛號

※直接點選進入醫師網路掛號畫面※

語言

  • 國語,英語,閩南語

現職

  • 高雄長庚醫院放射腫瘤科教授級主治醫師
  • 台灣放射腫瘤學會理事
  • 台灣癌症登記學會監事
  • 高雄長庚醫院癌症中心主任

學歷

  • 1992中國醫藥大學醫學系畢業
  • 2012長庚大學臨床醫學研究所博士畢業

經歷

  • 1990/6~1991/5:亞東醫院見習醫師
  • 1991/6~1992/6:台大醫院實習醫師(放射腫瘤科實習一個月)
  • 1994/6~1998/6:高雄長庚醫院放射腫瘤科住院醫師
  • 1998/7~2000/6:高雄長庚醫院放射腫瘤科一般級主治醫師
  • 2000/7~2003/6:高雄長庚醫院放射腫瘤科講師級主治醫師
  • 2000/8~ 2003/8:大仁技術學院兼任講師
  • 2003/8~ 2004/2 大仁技術學院兼任助理教授
  • 2003/7~2007/6:高雄長庚醫院放射腫瘤科助理教授級主治醫師
  • 2003/7~2008/12:教育部助理教授
  • 2003/9~ 2004/10 長庚大學醫學系兼任助理教授
  • 2004/11~2008/11: 長庚大學中醫學系專任助理教授
  • 2007/7~2014/6:高雄長庚醫院放射腫瘤科副教授級主治醫師
  • 2008/1~ 實證醫學小組委員
  • 2008/8~2015/1: 教育部副教授
  • 2008/12~2015/1: 長庚大學中醫學系副教授
  • 2009/1~ 動物實驗中心委員
  • 2009/7~2013/9: 高雄長庚醫院放射腫瘤科副主任
  • 2010/1~2015/9: 高雄長庚醫院癌症中心癌症登記負責醫師
  • 2012/9~~2015/9: 台灣癌症登記學會理事
  • 2013/10~: 高雄長庚醫院放射腫瘤科主任
  • 2014/2~: 高雄長庚醫院癌症中心副主任
  • 2014/5~: 台灣放射腫瘤學會理事
  • 2014/7:高雄長庚醫院放射腫瘤科教授級主治醫師
  • 2015/2~: 長庚大學中醫學系暨教育部教授
  • 2015/10~: 台灣癌症登記學會監事
  • 2015/10~: 高雄長庚醫院癌症中心主任
  • 2016/10~: 高雄長庚醫院生物統計中心癌登資料庫統計課程召集人

學會與認證

  • 台灣放射腫瘤學會(TASTRO)
  • 台灣乳房醫學會
  • 台灣癌症登記學會
  • 美國癌症研究學會(AACR)
  • 美國放射腫瘤學會(ASTRO)
  • 歐洲放射腫瘤學會(ESTRO)
  • 中華民國癌症醫學會
  • 台灣醫學教育學會
  • 公職醫師高考及格
  • 放射腫瘤專科醫師
  • 輻射防護師
  • 教育部教授
  • ACLS

論文及期刊發表

  • Results of Postoperative Electron Beam Irradiation for Stage Ⅱ and Ⅲ breast Cancer.
  • Treatment of Brain Arteriovenous Malformation (AVM) with Stereotactic Radiosurgery: Preliminary Result in Kaohsiung Chang Gung Memorial Hospital.
  • Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial.
  • Multivariate analysis of pulmonary fibrosis after electron beam irradiation for postmastectomy chest wall and regional lymphatics: evidence for non-dosimetric factors.
  • High external parametrial dose can increase the probability of radiation proctitis in patients with uterine cervix cancer.
  • Predictive factors for skin telangiectasia following post-mastectomy electron beam irradiation.
  • Dosimetric factors predicting severe radiation-induced bowel complications in patients with cervical cancer: combined effect of external parametrial dose and cumulative rectal dose.
  • Acute diarrhea during pelvic irradiation: is small-bowel volume effect different in gynecologic patients with prior abdomen operation or not?
  • The degree and time-course assessment of radiation-induced trismus occurring after radiotherapy for nasopharyngeal cancer.
  • Characteristics and predictive factors of early-onset diarrhea during pelvic irradiation.
  • Multivariate analyses of locoregional recurrences and skin complications following postmastectomy radiotherapy using electrons or photons.
  • The different volume effects of small-bowel toxicity during pelvic irradiation between gynecologic patients with and without abdominal surgery: a prospective study with computed tomography-based dosimetry.
  • Treatment Outcome following Three-dimensional Conformal Radiation Therapy (3D-CRT) for NK/T-cell Lymphoma of Nasal Cavity: A Single Institute Survey in Taiwan.
  • Multivariate analysis of para-aortic lymph node recurrence after definitive radiotherapy for stage IB-IVA squamous cell carcinoma of the uterine cervix.
  • Aminoguanidine alleviates radiation-induced small-bowel damage through its antioxidant effect.
  • Factors for predicting rectal dose of high-dose-rate intracavitary brachytherapy (HDR-ICBT) following pelvic irradiation in patients with cervical cancer: A retrospective study with radiography-based dosimetry.
  • Effect of non-equal weighting of four fields on small-bowel volume in gynecological patients undergoing whole-pelvic irradiation.
  • The prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
  • A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells.
  • Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix.
  • Post-operative low pelvic radiotherapy and chemotherapy for Stage II and III rectal cancer.
  • A prospective cohort study to compare treatment results between two fractionation schedules of high-dose-rate intracavitary brachytherapy (HDR-ICBT) in patients with cervical cancer.
  • Effect of different treatment plans on irradiated small-bowel volume in gynecologic patients undergoing whole-pelvic irradiation.
  • Prognostic factors of radiotherapy for cervical cancer with computed tomography-detected para-aortic lymph node metastasis.
  • Galectin-1 is an independent prognostic factor of local recurrence and survival after definitive radiotherapy for patients with squamous cell carcinoma of the uterine cervix.
長庚醫院智能服務 有任何問題隨時找我!